References
- Lagadinou M, Solomou EE, Zareifopoulos N, et al. Prognosis of COVID-19: changes in laboratory parameters. Le InfMed. 2020;28(Suppl. 1):89–95.
- Xia J, Tong J, Liu M, et al. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020;92(6):589–594.
- Han Y, Yang H. The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID-19): a Chinese perspective. J Med Virol. 2020;92(6):639–644.
- Liang H, Acharya G. Novel corona virus disease (COVID 19) in pregnancy: what clinical recommendations to follow? Acta Obstet Gynecol Scand. 2020;99(4):439–442.
- Chen Y, Peng H, Wang L, et al. Infants born to mothers with a new coronavirus (COVID-19). Front Pediatr. 2020;8:104.
- Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–95.
- Sahu KK, Lal A, Mishra AK. COVID-2019 and pregnancy: a plea for transparent reporting of all cases. Acta Obstet Gynecol Scand. 2020;99(7):951.
- Kosaryan M, Zafari M, Alipur A, et al. The effect and side effect of hydroxyurea therapy on patients with β-thalassemia: a systematic review to December 2012. Hemoglobin. 2014;38(4):262–271.
- Karimi M, Haghpanah S, Azarkeivan A, et al. Prevalence and mortality in β-thalassaemias due to outbreak of novel coronavirus disease (COVID-19): the nationwide Iranian experience. Br J Haematol. 2020;190(3):e137–e140.
- Motta I, Migone De Amicis M, Pinto VM, et al. SARS-CoV-2 infection in beta thalassemia: preliminary data from the Italian experience. Am J Hematol. 2020;95(8):E198–E199.
- Drouin E. Beta-thalassemia may protect against COVID 19. Med Hypotheses. 2020;143:110014.
- Lansiaux E, Pébaÿ PP, Picard J-L, et al. COVID-19: beta-thalassemia subjects immunised? Med Hypotheses. 2020;142:109827.
- Yadav U, Pal R. Challenging times for children with transfusion-dependent thalassemia amid the COVID-19 pandemic. Indian Pediatr. 2020;57(5):478.
- Taher AT, Bou-Fakhredin R, Kreidieh F, et al. Care of patients with hemoglobin disorders during the COVID-19 pandemic: an overview of recommendations. Am J Hematol. 2020;95(8):E208–E210.
- Sotoudeh E, Sotoudeh H. A hypothesis about the role of fetal hemoglobin in COVID-19. Med Hypotheses. 2020;144:109994. Online ahead of print.
- de Sanctis V, Canatan D, Corrons JLV, et al. Preliminary data on COVID-19 in patients with hemoglobinopathies: a multicentre ICET-A study. Mediterr J Hematol Infect Dis. 2020;12(1):e2020046.
- Beerkens F, John M, Puliafito B, et al. COVID 19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient. Am J Hematol. 2020;95(7): E-154–E156.
- Sasi S, Yassin MA, Nair AP, et al. A case of COVID-19 in a patient with asymptomatic Hemoglobin D thalassemia and glucose-6-phosphate dehydrogenase deficiency. Am J Case Rep. 2020;21:e925788.
- Dehshal MH, Hosoya S, Bahremani FH, et al. COVID-19 and thalassaemia in Iran. Thalassemia Reports. 2020;10(1):9157. DOI:https://doi.org/10.12659/AJCR.925788
- Marhaeni W, Wijaya AB, Kusumaningtyas P, et al. Thalassemic child presenting with anosmia due to COVID-19. Indian J Pediatr. 2020;87(9):750.
- Torti L, Maffei L, Sorrentino F, et al. Impact of SARS CoV-2 in hemoglobinopathies with immune disfunction and epidemiology. A protective mechanism from beta chain hemoglobin defects? Mediterr J Hematol Infect Dis. 2020;12(1):e2020052. Published online 2020 Jul 1. DOI:https://doi.org/10.4084/MJHID.2020.052.